Buyers eye Relypsa and its hyperkalemia drug

Eric Palmer

Redwood City, CA-based has hired an investment bank to check out M&A offers, Reuters reported. Relypsa isn't commenting but the news service says several companies that had previously bid on ZS Pharma, including Actelion, are eyeing Relypsa. 

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS